# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-19-035466
Filing Date
2019-07-23
Accepted
2019-07-23 08:00:41
Documents
74
Period of Report
2019-07-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tv525541_8k.htm | 8-K | 19465
2 | EXHIBIT 99.1 | tv525541_ex99-1.htm | EX-99.1 | 10433
3 | EXHIBIT 99.2 | tv525541_ex99-2.htm | EX-99.2 | 45812
4 | EXHIBIT 99.3 | tv525541_ex99-3.htm | EX-99.3 | 24352
5 | GRAPHIC | tv525541_logo.jpg | GRAPHIC | 5687
6 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 254154
7 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 186779
8 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 195966
9 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 207777
10 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 261359
11 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 272655
12 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 143047
13 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 271447
14 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 155194
15 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 138391
16 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 223150
17 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 187276
18 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 255097
19 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 151128
20 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 257130
21 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 216971
22 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 187139
23 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 231013
24 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 223049
25 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 151347
26 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 136425
27 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 104694
28 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 212764
29 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 103945
30 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 135205
31 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 244353
32 | GRAPHIC | ex99-2_027.jpg | GRAPHIC | 266389
33 | GRAPHIC | ex99-2_028.jpg | GRAPHIC | 158334
34 | GRAPHIC | ex99-2_029.jpg | GRAPHIC | 273710
35 | GRAPHIC | ex99-2_030.jpg | GRAPHIC | 169138
36 | GRAPHIC | ex99-2_031.jpg | GRAPHIC | 133680
37 | GRAPHIC | ex99-2_032.jpg | GRAPHIC | 142489
38 | GRAPHIC | ex99-2_033.jpg | GRAPHIC | 180868
39 | GRAPHIC | ex99-2_034.jpg | GRAPHIC | 251198
40 | GRAPHIC | ex99-2_035.jpg | GRAPHIC | 257097
41 | GRAPHIC | ex99-2_036.jpg | GRAPHIC | 172452
42 | GRAPHIC | ex99-2_037.jpg | GRAPHIC | 146799
43 | GRAPHIC | ex99-2_038.jpg | GRAPHIC | 242952
44 | GRAPHIC | ex99-2_039.jpg | GRAPHIC | 222425
45 | GRAPHIC | ex99-2_040.jpg | GRAPHIC | 184456
46 | GRAPHIC | ex99-2_041.jpg | GRAPHIC | 244226
47 | GRAPHIC | ex99-2_042.jpg | GRAPHIC | 143411
48 | GRAPHIC | ex99-2_043.jpg | GRAPHIC | 131734
49 | GRAPHIC | ex99-2_044.jpg | GRAPHIC | 204590
50 | GRAPHIC | ex99-2_045.jpg | GRAPHIC | 156243
51 | GRAPHIC | ex99-2_046.jpg | GRAPHIC | 171182
52 | GRAPHIC | ex99-2_047.jpg | GRAPHIC | 169691
53 | GRAPHIC | ex99-3_001.jpg | GRAPHIC | 259531
54 | GRAPHIC | ex99-3_002.jpg | GRAPHIC | 192015
55 | GRAPHIC | ex99-3_003.jpg | GRAPHIC | 214475
56 | GRAPHIC | ex99-3_004.jpg | GRAPHIC | 198870
57 | GRAPHIC | ex99-3_005.jpg | GRAPHIC | 230960
58 | GRAPHIC | ex99-3_006.jpg | GRAPHIC | 169060
59 | GRAPHIC | ex99-3_007.jpg | GRAPHIC | 183239
60 | GRAPHIC | ex99-3_008.jpg | GRAPHIC | 230996
61 | GRAPHIC | ex99-3_009.jpg | GRAPHIC | 151286
62 | GRAPHIC | ex99-3_010.jpg | GRAPHIC | 138386
63 | GRAPHIC | ex99-3_011.jpg | GRAPHIC | 185431
64 | GRAPHIC | ex99-3_012.jpg | GRAPHIC | 100936
65 | GRAPHIC | ex99-3_013.jpg | GRAPHIC | 160384
66 | GRAPHIC | ex99-3_014.jpg | GRAPHIC | 159987
67 | GRAPHIC | ex99-3_015.jpg | GRAPHIC | 154221
68 | GRAPHIC | ex99-3_016.jpg | GRAPHIC | 97494
69 | GRAPHIC | ex99-3_017.jpg | GRAPHIC | 143232
70 | GRAPHIC | ex99-3_018.jpg | GRAPHIC | 176008
71 | GRAPHIC | ex99-3_019.jpg | GRAPHIC | 135035
72 | GRAPHIC | ex99-3_020.jpg | GRAPHIC | 133898
73 | GRAPHIC | ex99-3_021.jpg | GRAPHIC | 212741
74 | GRAPHIC | ex99-3_022.jpg | GRAPHIC | 104155
| Complete submission text file | 0001144204-19-035466.txt |  | 17829840

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 19966798
SIC: 2834 Pharmaceutical Preparations